Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer

Published:2018-01 Issue: Volume:641 Page:248-258
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Mekala Janaki Ramaiah,Naushad Shaik Mohammad,Ponnusamy Lavanya,Arivazhagan Gayatri,Sakthiprasad Vaishnave,Pal-Bhadra Manika

Funder

Professor T. Rajagopalan Research

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference198 articles.

1. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma;Abe;Oncotarget,2017

2. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells;Ahmad;Mol. Cancer Ther.,2012

3. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells;Akao;Biol. Pharm. Bull.,2006

4. Identification of microRNAs and other tiny non-coding RNAs by cDNA cloning;Ambros;Methods Mol. Biol.,2004

5. Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges;Atadja;Cancer Lett.,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PHD2 safeguards modest mesendoderm development;Communications Biology;2024-09-07

2. Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer;Advanced Therapeutics;2024-03-25

3. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities;Frontiers in Cell and Developmental Biology;2024-03-14

4. A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer;Journal of Advanced Research;2023-12

5. Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3